Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature. (2018)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/mmbr.00051-17
PubMed Identifier: 29321222
Publication URI: http://europepmc.org/abstract/MED/29321222
Type: Journal Article/Review
Volume: 82
Parent Publication: Microbiology and molecular biology reviews : MMBR
Issue: 1
ISSN: 1092-2172